Pre-clinical studies of CDK8 human fusion-positive rhabdomyosarcoma
Research Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Ryvu Therapeutics
Start Date
August 1, 2022
End Date
August 1, 2024
Administered By
Pediatrics, Hematology-Oncology
Awarded By
Ryvu Therapeutics
Start Date
August 1, 2022
End Date
August 1, 2024